Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sophie Piperno-Neumann

Showing results (21-30 of 148) with videos related to

Pageof 15
Sort By:
British Journal of Cancer|March 29, 2022
Tumour growth rate improves tumour assessment and first-line systemic treatment decision-making for immunotherapy in patients with liver metastatic uveal melanomaToulsie Ramtohul, Axel Cohen, Manuel Rodrigues, et al.
BMC Psychiatry|November 16, 2024
Anxiety, depression and fear of cancer recurrence in uveal melanoma survivors and ophthalmologist/oncologist communication during survivorship in France - protocol of a prospective observational mixed-method studyAnita Müller, Sylvie Dolbeault, Sophie Piperno-Neumann, et al.
The British Journal of Ophthalmology|October 31, 2013
Genome-wide profiling is a clinically relevant and affordable prognostic test in posterior uveal melanomaNathalie Cassoux, Manuel Jorge Rodrigues, Corine Plancher, et al.
Nature Communications|February 5, 2016
Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usageSamar Alsafadi, Alexandre Houy, Aude Battistella, et al.
Frontiers in Oncology|June 26, 2023
A phase Ib trial of combined PKC and MEK inhibition with sotrastaurin and binimetinib in patients with metastatic uveal melanomaSebastian Bauer, James Larkin, F Stephen Hodi, et al.
Retina (Philadelphia, Pa.)|June 15, 2026
Safety and outcome of transscleral fine-needle aspiration biopsy in uveal melanoma: 10-year experience in 347 casesAlexandre Bourdin, Sylvain Dureau, Nathalie Algret, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 2014
Comparison of response evaluation criteria in solid tumours and Choi criteria for response evaluation in patients with advanced soft tissue sarcoma treated with trabectedin: a retrospective analysisSophie Taieb, Esma Saada-Bouzid, Emmanuelle Tresch, et al.
JMIR Research Protocols|January 12, 2022
Helping Patients Communicate With Oncologists When Cancer Treatment Resistance Occurs to Develop, Test, and Implement a Patient Communication Aid: Sequential Collaborative Mixed Methods StudyAnne Brédart, Aude Rault, Johanna Terrasson, et al.
British Journal of Cancer|July 29, 2025
Prognostic factors in patients with relapsed high-grade osteosarcoma: a systematic reviewAlba Rubio-San-Simón, William Wilson, Giovanna Sironi, et al.
Therapeutic Advances in Medical Oncology|September 4, 2023
Impact of the coronavirus disease 2019 pandemic on sarcoma management in France: a 2019 and 2020 comparisonNicolas Penel, Coralie Cantarel, Claire Chemin-Airiau, et al.
Pageof 15

Showing results (21-30 of 148) with videos related to

Sort By:
Pageof 15
British Journal of Cancer|March 29, 2022
Tumour growth rate improves tumour assessment and first-line systemic treatment decision-making for immunotherapy in patients with liver metastatic uveal melanomaToulsie Ramtohul, Axel Cohen, Manuel Rodrigues, et al.
BMC Psychiatry|November 16, 2024
Anxiety, depression and fear of cancer recurrence in uveal melanoma survivors and ophthalmologist/oncologist communication during survivorship in France - protocol of a prospective observational mixed-method studyAnita Müller, Sylvie Dolbeault, Sophie Piperno-Neumann, et al.
The British Journal of Ophthalmology|October 31, 2013
Genome-wide profiling is a clinically relevant and affordable prognostic test in posterior uveal melanomaNathalie Cassoux, Manuel Jorge Rodrigues, Corine Plancher, et al.
Nature Communications|February 5, 2016
Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usageSamar Alsafadi, Alexandre Houy, Aude Battistella, et al.
Frontiers in Oncology|June 26, 2023
A phase Ib trial of combined PKC and MEK inhibition with sotrastaurin and binimetinib in patients with metastatic uveal melanomaSebastian Bauer, James Larkin, F Stephen Hodi, et al.
Retina (Philadelphia, Pa.)|June 15, 2026
Safety and outcome of transscleral fine-needle aspiration biopsy in uveal melanoma: 10-year experience in 347 casesAlexandre Bourdin, Sylvain Dureau, Nathalie Algret, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 2014
Comparison of response evaluation criteria in solid tumours and Choi criteria for response evaluation in patients with advanced soft tissue sarcoma treated with trabectedin: a retrospective analysisSophie Taieb, Esma Saada-Bouzid, Emmanuelle Tresch, et al.
JMIR Research Protocols|January 12, 2022
Helping Patients Communicate With Oncologists When Cancer Treatment Resistance Occurs to Develop, Test, and Implement a Patient Communication Aid: Sequential Collaborative Mixed Methods StudyAnne Brédart, Aude Rault, Johanna Terrasson, et al.
British Journal of Cancer|July 29, 2025
Prognostic factors in patients with relapsed high-grade osteosarcoma: a systematic reviewAlba Rubio-San-Simón, William Wilson, Giovanna Sironi, et al.
Therapeutic Advances in Medical Oncology|September 4, 2023
Impact of the coronavirus disease 2019 pandemic on sarcoma management in France: a 2019 and 2020 comparisonNicolas Penel, Coralie Cantarel, Claire Chemin-Airiau, et al.
Pageof 15